Stephens, D. M., Ruppert, A. S., Maddocks, K., Andritsos, L., Baiocchi, R., Jones, J., . . . Flynn, J. M. (2013). Cyclophosphamide, Alvocidib (Flavopiridol), and Rituximab, a Novel Feasible Chemoimmunotherapy Regimen for Patients with High-Risk Chronic Lymphocytic Leukemia.
Style de citation ChicagoStephens, Deborah M., et al. Cyclophosphamide, Alvocidib (Flavopiridol), and Rituximab, a Novel Feasible Chemoimmunotherapy Regimen for Patients With High-Risk Chronic Lymphocytic Leukemia. 2013.
Style de citation MLAStephens, Deborah M., et al. Cyclophosphamide, Alvocidib (Flavopiridol), and Rituximab, a Novel Feasible Chemoimmunotherapy Regimen for Patients With High-Risk Chronic Lymphocytic Leukemia. 2013.
Attention : ces citations peuvent ne pas être correctes à 100%.